CoChat
Sign Up
Cited by 30

The DOI matches its Crossref record.

Advanced Heart Failure Therapies for Hypertrophic Cardiomyopathy

Liang, Lusha W., Lumish, Heidi S., Sewanan, Lorenzo R., Shimada, Yuichi J., Maurer, Mathew S., Weiner, Shepard D., Sayer, Gabriel, Uriel, Nir, Clerkin, Kevin J.·2023·JACC: Heart Failure
DOI 10.1016/j.jchf.2023.07.004PMC PMC13000544
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jchf.2023.07.004

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 21

  1. Rowin, 2020, Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction, J Am Coll Cardiol, 75, 3033, 10.1016/j.jacc.2020.04.045 · DOI
  2. Pasqualucci, 2015, Clinical spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy, Circ Heart Fail, 8, 1014, 10.1161/CIRCHEARTFAILURE.114.001843 · DOI · Paper page
  3. Ho, 2018, Genotype and lifetime burden of disease in hypertrophic cardiomyopathy, Circulation, 138, 1387, 10.1161/CIRCULATIONAHA.117.033200 · DOI · Paper page
  4. Harris, 2006, Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy, Circulation, 114, 216, 10.1161/CIRCULATIONAHA.105.583500 · DOI
  5. Fernández, 2011, Comparison of prevalence, clinical course, and pathological findings of left ventricular systolic impairment versus normal systolic function in patients with hypertrophic cardiomyopathy, Am J Cardiol, 108, 548, 10.1016/j.amjcard.2011.03.083 · DOI
  6. Rowin, 2018, Impact of advanced therapies for improving survival to heart transplant in patients with hypertrophic cardiomyopathy, Am J Cardiol, 121, 986, 10.1016/j.amjcard.2017.12.044 · DOI
  7. Maron, 2018, Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy, J Am Coll Cardiol HF, 6, 353
  8. Olivotto, 2010, Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy, Am J Cardiol, 106, 261, 10.1016/j.amjcard.2010.03.020 · DOI
  9. Mehra, 2016, The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update, J Heart Lung Transplant, 35, 1, 10.1016/j.healun.2015.10.023 · DOI
  10. Coats, 2015, Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy, Circ Heart Fail, 8, 1022, 10.1161/CIRCHEARTFAILURE.114.002248 · DOI · Paper page
  11. Sorajja, 2012, Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy, Am J Cardiol, 109, 1494, 10.1016/j.amjcard.2012.01.363 · DOI
  12. Rowin, 2014, Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy, Circ Heart Fail, 7, 967, 10.1161/CIRCHEARTFAILURE.114.001435 · DOI
  13. Mehra, 2019, A fully magnetically levitated left ventricular assist device—final report, N Engl J Med, 380, 1618, 10.1056/NEJMoa1900486 · DOI
  14. Kawabori, 2019, A left ventricular end-diastolic dimension less than 6.0 cm is associated with mortality after implantation of an axial-flow pump, J Thorac Cardiovasc Surg, 157, 2302, 10.1016/j.jtcvs.2019.01.015 · DOI
  15. Shah, 2017, Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: an Interagency Registry for Mechanically Assisted Circulatory Support Analysis, J Heart Lung Transplant, 36, 640, 10.1016/j.healun.2016.12.004 · DOI
  16. Patel, 2017, Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: an INTERMACS analysis, J Card Fail, 23, 859, 10.1016/j.cardfail.2017.09.011 · DOI
  17. Topilsky, 2011, Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy, Circ Heart Fail, 4, 266, 10.1161/CIRCHEARTFAILURE.110.959288 · DOI
  18. Muthiah, 2013, Centrifugal continuous-flow left ventricular assist device in patients with hypertrophic cardiomyopathy: a case series, ASAIO J, 59, 183, 10.1097/MAT.0b013e318286018d · DOI
  19. Rowin, 2020, Reply: The LVAD in the management of advanced heart failure due to hypertrophic cardiomyopathy, J Am Coll Cardiol, 76, 1913, 10.1016/j.jacc.2020.08.022 · DOI
  20. Maron, 2010, Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy, Circ Heart Fail, 3, 574, 10.1161/CIRCHEARTFAILURE.109.922872 · DOI
  21. Cisneros, 2018, Outcomes in patients with hypertrophic cardiomyopathy awaiting heart transplantation, Circ Heart Fail, 11

Cited by

Sorted by citations

Metadata

Authors
Liang, L. W., Lumish, H. S., Sewanan, L. R., Shimada, Y. J., Maurer, M. S., Weiner, S. D., Sayer, G., Uriel, N., & Clerkin, K. J.
Venue
JACC: Heart Failure
Publisher
Elsevier BV
Published
2023-11
Volume
11
Issue
11
Pages
1473-1480
ISSN
2213-1779
DOI
10.1016/j.jchf.2023.07.004
PMC
PMC13000544
Cited by
30
References
0
Language
en
Licence
Funders
NHLBI

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review